APA (7th ed.) Citation

Xiong, Y., Guo, Y., Liu, Y., Wang, H., Gong, W., Liu, Y., . . . Jiang, B. (2020). Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor. Neoplasia (New York, N.Y.), 22(9), 431-440. https://doi.org/10.1016/j.neo.2020.06.009

Chicago Style (17th ed.) Citation

Xiong, Yao, et al. "Pamiparib Is a Potent and Selective PARP Inhibitor with Unique Potential for the Treatment of Brain Tumor." Neoplasia (New York, N.Y.) 22, no. 9 (2020): 431-440. https://doi.org/10.1016/j.neo.2020.06.009.

MLA (9th ed.) Citation

Xiong, Yao, et al. "Pamiparib Is a Potent and Selective PARP Inhibitor with Unique Potential for the Treatment of Brain Tumor." Neoplasia (New York, N.Y.), vol. 22, no. 9, 2020, pp. 431-440, https://doi.org/10.1016/j.neo.2020.06.009.